IL-17A contributes to the pathogenesis of endometriosis by triggering proinflammatory cytokines and angiogenic growth factors

Journal of Immunology

Volumn 195, Issue 6, 2015, Pages 2591-2600

  Ahn, Soo Hyun ^a   Edwards, Andrew K ^a   Singh, Sukhbir S ^b   Young, Steven L ^c   Lessey, Bruce A ^d   Tayade, Chandrakant ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d GREENVILLE HOSPITAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; FRACTALKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; CX3CL1 PROTEIN, HUMAN; CXCL1 PROTEIN, HUMAN; CXCL12 PROTEIN, HUMAN; IL17A PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; CARCINOMA CELL; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LAPAROSCOPIC SURGERY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; ADULT; BIOSYNTHESIS; BLOOD; CELL LINE; ENDOMETRIUM TUMOR; IMMUNOLOGY; INFLAMMATION; LAPAROSCOPY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SURGERY; VASCULARIZATION; YOUNG ADULT;

ADULT; CELL LINE; CHEMOKINE CX3CL1; CHEMOKINE CXCL1; CHEMOKINE CXCL12; ENDOMETRIAL NEOPLASMS; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LAPAROSCOPY; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84941785064     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501138     Document Type: Article

References (40)

1. Murphy, A. A. 2002. Clinical aspects of endometriosis. Ann. N. Y. Acad. Sci. 955: 1-10, discussion 34-36, 396-406.
2. Vercellini, P., P. Viganò, E. Somigliana, and L. Fedele. 2014. Endometriosis: pathogenesis and treatment. Nat. Rev. Endocrinol. 10: 261-275.
3. Edwards, A. K., D. S. Nakamura, S. Virani, J. M. Wessels, and C. Tayade. 2013. Animal models for anti-angiogenic therapy in endometriosis. J. Reprod. Immunol. 97: 85-94.
4. Laschke, M. W., and M. D. Menger. 2012. Anti-angiogenic treatment strategies for the therapy of endometriosis. Hum. Reprod. Update 18: 682-702.
5. Nap, A. W., A. W. Griffioen, G. A. Dunselman, J. C. Bouma-Ter Steege, V. L. Thijssen, J. L. Evers, and P. G. Groothuis. 2004. Antiangiogenesis therapy for endometriosis. J. Clin. Endocrinol. Metab. 89: 1089-1095.
6. Sampson, J. A. 1940. The development of the implantation theory for the origin of peritoneal endometriosis. Am. J. Obstet. Gynecol. 40: 549-557.
7. Herington, J. L., K. L. Bruner-Tran, J. A. Lucas, and K. G. Osteen. 2011. Immune interactions in endometriosis. Expert Rev. Clin. Immunol. 7: 611-626.
8. Lin, Y.-J., M.-D. Lai, H.-Y. Lei, and L.-Y. C. Wing. 2006. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology 147: 1278-1286.
9. Hornung, D., F. Bentzien, D. Wallwiener, L. Kiesel, and R. N. Taylor. 2001. Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid. Mol. Hum. Reprod. 7: 163-168.
10. McLaren, J., A. Prentice, D. S. Charnock-Jones, S. A. Millican, K. H. Müller, A. M. Sharkey, and S. K. Smith. 1996. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Invest. 98: 482-489.
11. Schulke, L., M. Berbic, F. Manconi, N. Tokushige, R. Markham, and I. S. Fraser. 2009. Dendritic cell populations in the eutopic and ectopic endometrium of women with endometriosis. Hum. Reprod. 24: 1695-1703.
12. Hirata, T., Y. Osuga, M. Takamura, A. Kodama, Y. Hirota, K. Koga, O. Yoshino, M. Harada, Y. Takemura, T. Yano, and Y. Taketani. 2010. Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells. Endocrinology 151: 5468-5476.
13. Gazvani, R., and A. Templeton. 2002. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 123: 217-226.
14. Berbic, M., and I. S. Fraser. 2011. Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J. Reprod. Immunol. 88: 149-155.
15. Fossiez, F., O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J. J. Pin, P. Garrone, E. Garcia, S. Saeland, et al. 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183: 2593-2603.
16. Song, X., and Y. Qian. 2013. IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases. Cell. Signal. 25: 2335-2347.
17. Zou, W., and N. P. Restifo. 2010. T(H)17 cells in tumour immunity and immunotherapy. Nat. Rev. Immunol. 10: 248-256.
18. Toy, D., D. Kugler, M. Wolfson, T. Vanden Bos, J. Gurgel, J. Derry, J. Tocker, and J. Peschon. 2006. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177: 36-39.
19. Martin, B., K. Hirota, D. J. Cua, B. Stockinger, and M. Veldhoen. 2009. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321-330.
20. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
21. Rei, M., N. Goncalves-Sousa, T. Lanca, R. G. Thompson, S. Mensurado, F. R. Balkwill, H. Kulbe, D. J. Pennington, and B. Silva-Santos. 2014. Murine CD27(-) Vg6(+) gd T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages. Proc. Natl. Acad. Sci. USA 111: E3562-E3570.
22. Passos, S. T., J. S. Silver, A. C. O'Hara, D. Sehy, J. S. Stumhofer, and C. A. Hunter. 2010. IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J. Immunol. 184: 1776-1783.
23. Le Jan, S., J. Plée, D. Vallerand, A. Dupont, E. Delanez, A. Durlach, P. L. Jackson, J. E. Blalock, P. Bernard, and F. Antonicelli. 2014. Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid. J. Invest. Dermatol. 134: 2908-2917.
24. Hueber, A. J., D. L. Asquith, A. M. Miller, J. Reilly, S. Kerr, J. Leipe, A. J. Melendez, and I. B. McInnes. 2010. Mast cells express IL-17A in rheumatoid arthritis synovium. J. Immunol. 184: 3336-3340.
25. Miossec, P., and J. K. Kolls. 2012. Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11: 763-776.
26. Lu, S., H. Li, R. Gao, X. Gao, F. Xu, Q. Wang, G. Lu, D. Xia, and J. Zhou. 2015. IL-17A, but not IL-17F, is indispensable for airway vascular remodeling induced by exaggerated Th17 cell responses in prolonged ovalbumin-challenged mice. J. Immunol. 194: 3557-3566.
27. Chung, A. S., X. Wu, G. Zhuang, H. Ngu, I. Kasman, J. Zhang, J. M. Vernes, Z. Jiang, Y. G. Meng, F. V. Peale, et al. 2013. An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nat. Med. 19: 1114-1123.
28. Hirata, T., Y. Osuga, K. Hamasaki, O. Yoshino, M. Ito, A. Hasegawa, Y. Takemura, Y. Hirota, E. Nose, C. Morimoto, et al. 2008. Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cells. Endocrinology 149: 1260-1267.
29. Zhang, X., H. Xu, J. Lin, Y. Qian, and L. Deng. 2005. Peritoneal fluid concentrations of interleukin-17 correlate with the severity of endometriosis and infertility of this disorder. BJOG 112: 1153-1155.
30. Donnez, J., P. Smoes, S. Gillerot, F. Casanas-Roux, and M. Nisolle. 1998. Vascular endothelial growth factor (VEGF) in endometriosis. Hum. Reprod. 13: 1686-1690.
31. Virani, S., A. K. Edwards, R. Thomas, T. Childs, and C. Tayade. 2013. Blocking of stromal cell-derived factor-1 reduces neoangiogenesis in human endometriosis lesions in a mouse model. Am. J. Reprod. Immunol. 70: 386-397.
32. Laschke, M.W., C. Giebels, R. M. Nickels, C. Scheuer, and M. D. Menger. 2011. Endothelial progenitor cells contribute to the vascularization of endometriotic lesions. Am. J. Pathol. 178: 442-450.
33. Roy, L. D., M. Sahraei, J. L. Schettini, H. E. Gruber, D. M. Besmer, and P. Mukherjee. 2014. Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches. BMC Cancer 14: 225.
34. Fossiez, F., J. Banchereau, R. Murray, C. Van Kooten, P. Garrone, and S. Lebecque. 1998. Interleukin-17. Int. Rev. Immunol. 16: 541-551.
35. Yao, Z., M. K. Spriggs, J. M. Derry, L. Strockbine, L. S. Park, T. VandenBos, J. D. Zappone, S. L. Painter, and R. J. Armitage. 1997. Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 9: 794-800.
36. Jin, D. K., K. Shido, H. G. Kopp, I. Petit, S. V. Shmelkov, L. M. Young, A. T. Hooper, H. Amano, S. T. Avecilla, B. Heissig, et al. 2006. Cytokinemediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat. Med. 12: 557-567.
37. Imaizumi, T., H. Yoshida, and K. Satoh. 2004. Regulation of CX3CL1/ fractalkine expression in endothelial cells. J. Atheroscler. Thromb. 11: 15-21.
38. Volin, M. V., N. Huynh, K. Klosowska, R. D. Reyes, and J. M. Woods. 2010. Fractalkine-induced endothelial cell migration requires MAP kinase signaling. Pathobiology 77: 7-16.
39. Imaizumi, T., T. Matsumiya, K. Fujimoto, K. Okamoto, X. Cui, U. Ohtaki, Hidemi, Yoshida, and K. Satoh. 2000. Interferon-g stimulates the expression of CX3CL1/ fractalkine in cultured human endothelial cells. Tohoku J. Exp. Med. 192: 127-139.
40. Pickens, S. R., M. V. Volin, A. M. Mandelin, II, J. K. Kolls, R. M. Pope, and S. Shahrara. 2010. IL-17 contributes to angiogenesis in rheumatoid arthritis. J. Immunol. 184: 3233-3241.